JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
CALL
Nike
NKE
$50.4B
| $10.1M | ﹤0.01% |
86,500
+40,000
| +86% | +$4.03M |
2016 Q1
27 quarters
|
|
|
DCP
2152
CALL
DELISTED
DCP Midstream, LP
DCP
| $10.1M | ﹤0.01% |
260,900
+212,900
| +444% | +$8.24M |
2022 Q3
1 quarter
|
|
2153
Madison Square Garden
MSGS
$9.64B
| $10.1M | ﹤0.01% |
55,144
+4,686
| +9% | +$735K |
2013 Q2
38 quarters
|
|
2154
CALL
Legend Biotech
LEGN
$3.65B
| $10.1M | ﹤0.01% |
202,000
-36,500
| -15% | -$1.77M |
2022 Q1
3 quarters
|
|
2155
Fulgent Genetics
FLGT
$618M
| $10.1M | ﹤0.01% |
337,736
+144,660
| +75% | +$5.18M |
2020 Q2
10 quarters
|
|
2156
Viavi Solutions
VIAV
$11.5B
| $10M | ﹤0.01% |
955,928
+87,476
| +10% | +$1.05M |
2013 Q2
38 quarters
|
|
|
AKRO
2157
DELISTED
Akero Therapeutics
AKRO
| $10M | ﹤0.01% |
183,315
-52,214
| -22% | -$2.24M |
2019 Q3
13 quarters
|
|
2158
First Financial Corp
THFF
$888M
| $10M | ﹤0.01% |
217,593
+8,252
| +4% | +$390K |
2013 Q2
38 quarters
|
|
2159
Wabash National
WNC
$570M
| $10M | ﹤0.01% |
443,058
-347,193
| -44% | -$7.53M |
2013 Q2
38 quarters
|
|
2160
CALL
Dollar General
DG
$26.3B
| $10M | ﹤0.01% |
40,600
+400
| +1% | +$98.9K |
2021 Q3
5 quarters
|
|
|
SLY
2161
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $9.99M | ﹤0.01% |
121,514
+81,268
| +202% | +$6.77M |
2018 Q4
16 quarters
|
|
2162
Jackson Financial
JXN
$9.07B
| $9.96M | ﹤0.01% |
286,428
+211,620
| +283% | +$7.35M |
2021 Q3
5 quarters
|
|
2163
LeMaitre Vascular
LMAT
$1.85B
| $9.95M | ﹤0.01% |
216,264
-19,632
| -8% | -$919K |
2016 Q3
25 quarters
|
|
|
NXRT
2164
NexPoint Residential Trust
NXRT
$475M
| $9.95M | ﹤0.01% |
228,675
-42,432
| -16% | -$1.9M |
2015 Q4
28 quarters
|
|
2165
Primerica
PRI
$8.56B
| $9.94M | ﹤0.01% |
70,085
-1,397
| -2% | -$195K |
2013 Q2
38 quarters
|
|
2166
CALL
American Tower
AMT
$75.6B
| $9.94M | ﹤0.01% |
46,900
-48,500
| -51% | -$10.1M |
2021 Q2
6 quarters
|
|
2167
Materion
MTRN
$6.65B
| $9.93M | ﹤0.01% |
113,462
+3,034
| +3% | +$248K |
2016 Q4
24 quarters
|
|
2168
Choice Hotels
CHH
$4.48B
| $9.93M | ﹤0.01% |
88,138
-22,545
| -20% | -$2.69M |
2014 Q3
33 quarters
|
|
2169
News Corp Class A
NWSA
$15.6B
| $9.91M | ﹤0.01% |
544,405
-180,042
| -25% | -$3.13M |
2013 Q3
37 quarters
|
|
|
UPWD
2170
DELISTED
JPMorgan Social Advancement ETF
UPWD
| $9.91M | ﹤0.01% |
200,000
| – | – |
2022 Q3
1 quarter
|
|
2171
PUT
Ovintiv
OVV
$16.9B
| $9.9M | ﹤0.01% |
+195,300
| New | +$10.2M |
2022 Q4
0 quarters
|
|
2172
Veeco
VECO
$3.44B
| $9.9M | ﹤0.01% |
532,916
+2,953
| +0.6% | +$55.5K |
2016 Q3
25 quarters
|
|
2173
Delek US
DK
$4.62B
| $9.89M | ﹤0.01% |
366,509
-121,177
| -25% | -$3.58M |
2013 Q2
38 quarters
|
|
2174
NCR Voyix
VYX
$944M
| $9.89M | ﹤0.01% |
688,949
-16,950
| -2% | -$225K |
2013 Q2
38 quarters
|
|
|
UNIT
2175
Uniti Group
UNIT
$1.93B
| $9.88M | ﹤0.01% |
1,786,588
+1,110,891
| +164% | +$7.63M |
2015 Q2
30 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.